arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

DaVita Inc.

DVA Health Care Misc Health and Biotechnology Services
$183.94
▼ -0.0% Today
as of Sep 4, 16:48 ET
Last 30 days -23.16% Jul 28 → Sep 04
$168.45 $187.92 $207.39 $226.86 $246.33 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$180.97
High
$184.13
Low
$179.95
Volume
$449,420
Avg Vol
$904,793
Mkt Cap
$11.4B
P/E (TTM)
20.60
Beta
—
52w High
$247.49
52w Low
$101.00
Div Yield
—
Shares Out
$64M

Recent Press Releases & News last 60 days · 25 items

Sep 4 · 16:20 PR ACCESS Newswire
DaVita Community Care Report 2025: Leading With Integrity and Accountability
Sep 4 · 11:13 Simply Wall St.
DaVita (DVA) Has Investors Asking A Fresh Question
Sep 3 · 15:30 Zacks
Why Is DaVita HealthCare (DVA) Down 4.9% Since Last Earnings Report?
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$101
$247
57% of range
Avg surprise (last 3)
+14.2%
Avg reaction (last 2)
+1.2%
100% positive
Latest IV / EM
28%
EM ±4.3% · $185 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.25$1.94$2.63$3.33$4.02 Actual $1.25Actual $1.91Actual $2.62Actual $2.65Actual $2.50Actual $2.50Actual $2.00Est $1.75Actual $2.95Est $2.70Actual $2.04Actual $2.87Est $2.41Actual $4.02 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$933M$1.9B$2.8B$3.7B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $4.02 — — — — financials
Tue May 5, 2026Mar/2026 $2.87 $2.41 +19.1% +43.5% +1.9% earnings
Tue Sep 30, 2025Sep 2025 $2.04 — — — — financials
Tue Aug 5, 2025Jun/2025 $2.95 $2.70 +9.3% — — earnings
Mon May 12, 2025Mar/2025 $2.00 $1.75 +14.3% — +0.5% earnings
Mon Sep 30, 2024Sep 2024 $2.50 — — — — financials
Sun Jun 30, 2024Jun 2024 $2.50 — — — — financials
Sun Mar 31, 2024Mar 2024 $2.65 — — — — financials
Sat Sep 30, 2023Sep 2023 $2.62 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.91 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.25 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$3.55B$3.42B—$3.42B$3.38B$3.22B—$3.26B
Cost of revenue————————
Gross profit————————
Operating income$579M$482M—$506M$538M$439M—$535M
Net income$265M$198M—$150M$199M$163M—$215M
EPS (diluted)$4.02$2.87—$2.04$2.58$2.00—$2.50

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$669M$644M$676M$706M$708M$439M$795M$1.07B
Inventory$152M$142M$161M$139M$146M$151M$135M$129M
Total current assets$4.19B$4.06B$4.06B$4.11B$4.09B$3.64B$3.75B$4.04B
Total assets$17.71B$17.50B$17.48B$17.56B$17.49B$17.12B$17.29B$17.50B
Long-term debt————————
Total liabilities$16.63B$16.45B$16.32B$16.22B$15.94B$15.46B$15.19B$15.28B
Total equity$-765M$-755M$-651M$-572M$-370M$-267M$121M$387M

Implied volatility — last 90 days

22%101%180%260%339% Jun 07 — IV 39% · EM ±5.3%Jun 08 — IV 37% · EM ±4.8%Jun 09 — IV 38% · EM ±4.7%Jun 10 — IV 39% · EM ±4.7%Jun 11 — IV 42% · EM ±4.6%Jun 12 — IV 33% · EM ±3.4%Jun 15 — IV 39% · EM ±2.8%Jun 16 — IV 22% · EM ±1.3%Jun 17 — IV 43% · EM ±1.8%Jun 19 — IV 32% · EM ±7.2%Jun 22 — IV 34% · EM ±7.0%Jun 23 — IV 34% · EM ±7.0%Jun 24 — IV 34% · EM ±6.9%Jun 25 — IV 33% · EM ±6.4%Jun 26 — IV 32% · EM ±6.2%Jun 29 — IV 33% · EM ±5.8%Jun 30 — IV 32% · EM ±5.6%Jul 01 — IV 33% · EM ±5.4%Jul 02 — IV 36% · EM ±5.8%Jul 03 — IV 37% · EM ±5.8%Jul 06 — IV 37% · EM ±5.2%Jul 07 — IV 36% · EM ±4.8%Jul 08 — IV 35% · EM ±4.4%Jul 09 — IV 33% · EM ±3.9%Jul 10 — IV 34% · EM ±3.7%Jul 13 — IV 44% · EM ±3.7%Jul 14 — IV 42% · EM ±3.1%Jul 15 — IV 42% · EM ±2.5%Jul 16 — IV 92% · EM ±3.8%Jul 20 — IV 50% · EM ±11.8%Jul 21 — IV 51% · EM ±11.9%Jul 22 — IV 53% · EM ±12.1%Jul 23 — IV 54% · EM ±12.1%Jul 24 — IV 53% · EM ±11.8%Jul 27 — IV 56% · EM ±11.7%Jul 28 — IV 56% · EM ±11.5%Jul 29 — IV 57% · EM ±11.4%Jul 30 — IV 55% · EM ±10.8%Jul 31 — IV 58% · EM ±11.1%Aug 03 — IV 62% · EM ±11.1%Aug 04 — IV 79% · EM ±13.6%Aug 05 — IV 45% · EM ±7.4%Aug 06 — IV 37% · EM ±5.9%Aug 07 — IV 36% · EM ±5.6%Aug 10 — IV 34% · EM ±4.7%Aug 11 — IV 340% · EM ±44.8%Aug 12 — IV 34% · EM ±4.3%Aug 13 — IV 33% · EM ±3.9%Aug 14 — IV 28% · EM ±3.0%Aug 17 — IV 32% · EM ±2.7%Aug 18 — IV 38% · EM ±2.8%Aug 19 — IV 39% · EM ±2.3%Aug 20 — IV 35% · EM ±1.5%Aug 24 — IV 32% · EM ±6.6%Aug 25 — IV 31% · EM ±6.3%Aug 26 — IV 29% · EM ±5.9%Aug 27 — IV 29% · EM ±5.6%Aug 28 — IV 29% · EM ±5.5%Aug 31 — IV 29% · EM ±5.1%Sep 01 — IV 29% · EM ±5.0%Sep 02 — IV 29% · EM ±4.8%Sep 03 — IV 27% · EM ±4.4%Sep 04 — IV 28% · EM ±4.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in